define({
	"fr": false,
	"root": {

		"sections": {

		},

		"commons": {
			"yes-of": "Yes, officially",
			"yes-no": "Yes, not officially",
			"no": "No",
			"not": "Not sure"
		},

		"contact_info":       "Contact Information",
			"contact_info_1": "Date",
			"contact_info_2": "Country Name",
			"contact_info_3": "Name",
			"contact_info_4": "Email",
			"contact_info_5": "Phone",
			"contact_info_6": "Street address",

		"contact_person":             "Please, complete the person in contact for each which applied",
			"contact_person_1":       "FMD PCP specialist:",
				"contact_person_1_1": "Name:",
				"contact_person_1_2": "eMail",
			"contact_person_2":       "FMD Laboratory specialist",
				"contact_person_2_1": "Name",
				"contact_person_2_2": "eMail:",
			"contact_person_3":       "FMD Epidemiology specialist",
				"contact_person_3_1": "Name:",
				"contact_person_3_2": "eMail:",

		"cat1": "GENERAL INFORMATION",

			"ask1":       "1) Has your country identified a list of Priority Transboundary Animal Diseases (TAD)?",
				"ask1_1": "If yes, list the 5 highest priority diseases",

		"cat2": "LIVESTOCK POPULATION",

			"ask2":       "2) Please, provide information on population of FMD-susceptible livestock and wild life in your country? (Multiple answer, fill in the boxes)",

			"ask2_1":      "2_1) Domestic Species",

			"ask2_1_1":    "Cattle",
				"ask2_1_1_1":  "Number",
				"ask2_1_1_2":  "Census year",
			  
			"ask2_1_2":  "Buffalo",
				"ask2_1_2_1":  "Number",
				"ask2_1_2_2":  "Census year",

			"ask2_1_3":  "Sheep",
				"ask2_1_3_1":  "Number",
				"ask2_1_3_2":  "Census year",
			"ask2_1_4":  "Goat",
				"ask2_1_4_1":  "Number",
				"ask2_1_4_2":  "Census year",
			"ask2_1_5":  "Pigs",
				"ask2_1_5_1":  "Number",
				"ask2_1_5_2":  "Census year",
			"ask2_1_6":  "Other Domestic Species",
				"ask2_1_6_1":  "Number",
				"ask2_1_6_2":  "Census year",

			"ask2_2":			 "2_2) FMD susceptible Wild Life species",
			"ask2_2_1": 		"Buffalo",
				"ask2_2_1_1": 		"presence",
				"ask2_2_1_2": 		"Approximate population number (if known)",
			"ask2_2_2": 		"Antelope",
				"ask2_2_2_1":			"presence",
				"ask2_2_2_2":				"Approximate population number (if known)",
			"ask2_2_3": 	"Deer",
				"ask2_2_3_1":			"presence",
				"ask2_2_3_2":			"Approximate population number (if known)",
			"ask2_2_4": 	"Wild boar",
				"ask2_2_4_1":			"presence",
				"ask2_2_4_2":			"Approximate population number (if known)",

			"ask2_2_5":		"Feral pigs",
				"ask2_2_5_1":			"presence",
				"ask2_2_5_2":			"Approximate population number (if known)",

			"ask2_2_6": 	"Other (specify)",
				"ask2_2_6_1":			"presence",
				"ask2_2_6_2":			"Approximate population number (if known)",

		"cat3": "FARM REGISTER",

			"ask3":       "3) Is there an official livestock establishment registration system in your country?",
				"ask3_1": "Please, specify the sector(s):",

		"cat4": "ANIMAL IDENTIFICATION",

			"ask4":             "4) Is there an official system of animal identification and registration?",
				"ask4_1":       "a) Large Ruminants:",
					"ask4_1_1": "Please, specify the sector(s):",
				"ask4_2":       "b) Small Ruminants:",
					"ask4_2_1": "Please, specify the sector(s):",
				"ask4_3":       "c) Pigs:",
					"ask4_3_1": "Please, specify the sector(s):",
					

		"cat5": "ANIMAL MOVEMENTS",

			"ask5":        "5) Is animal movement monitored?",
			"ask6":        "6) Are data routinely collected on the number, origin and destination of livestock traded?(Exclusive answers)",

		"cat6": "FMD OUTBREAKS",

			"ask7":        "7) Number of FMD outbreaks detected in your country since 2012:      (An outbreak is defined as a FMD case in an epi-unit (farm, village, dip-tank location) with FMD clinical signs of FMD_ It does not refer to the number of animals affected within an epi-unit_)",
			"ask7_1": "2014 (to date) ",
						"ask7_1_1":"Number of FMD outbreaks detected",
						"ask7_1_2":"Serotype(s) involved (if unknown, please indicate with ‘unk’)",
			"ask7_2": "2013",	
						"ask7_2_1":"Number of FMD outbreaks detected",
						"ask7_2_2":"Serotype(s) involved (if unknown, please indicate with ‘unk’)",
			"ask7_3": "2012",
						"ask7_3_1":"Number of FMD outbreaks detected",
						"ask7_3_2":"Serotype(s) involved (if unknown, please indicate with ‘unk’)",
			
			"ask8":        "8) Is there a laboratory specialized in FMD diagnosis in your country? (Exclusive answers)",
			"ask9":        "9) When an outbreak of FMD is notified, is an outbreak investigation conducted? (Exclusive answers)",
				"ask9_1":  "Other:",
				"ask9_2":  "Would you need/want assistance to deal with outbreak investigation?",

			"ask10":             "10) What activities are undertaken during an outbreak investigation(multiple choices)",
				"ask10_1":       "a) Forward and backward tracing – attempting to identify routes of FMD virus transmission_ (exclusive answer)",
					"ask10_1_1": "If no, why?",
				"ask10_2":       "b) Sampling for confirmation – FMD laboratory diagnosis",
				"ask10_3":       "c) Followed by identification of serotype",
				"ask10_4":       "d) Followed by sequencing of genotype",
				"ask10_5":       "e) Are samples shipped to an International Reference Laboratory for further analysis?",
				
			"ask11":       "11) What additional control measures are applied when an outbreak occurs in your country?(select all that apply)(multiple answer)",
				"ask11_1": "Other:",
			
			"ask12":       "12) Has your country adopted legislation to enforce/support these measures? (exclusive answer)",
			"ask13":       "13) Does your country have a written and government endorsed FMD Contingency Plan?",
			"ask14":       "14) If yes, has your country implemented or exercised the FMD Contingency Plan within the last 12 months?",
				"ask14_1": "If yes, please specify:",

			"ask15":       "15) Is the written FMD Contingency Plan available for our review?",

		"cat7": "IDENTIFICATION OF RISK FACTORS AND HOTSPOTS",

			"ask16":       "16) Has your country determined the risk factors for FMD?",
				"ask16_1": "If yes, which year?",
				"ask16_2": "Which risk factors have been identified? (Please, list approx_ 5)",
			"ask17":       "17) Has your country determined risk hotspots for FMD?",
				"ask17_1": "If yes, which year?",
				"ask17_2": "Which risk hotspots have been identified? (Please, list approx_ 5)",

		"cat8": "FMD CONTROL",

			"ask18":         "18) Does your country have a written and government endorsed FMD control strategy?",

			"ask18_1":       "18_1) If yes",
				"ask18_1_1": "Which year was it endorsed?",
				"ask18_1_2": "Is this control plan developed along the lines of a Risk-Based Strategy?",
				"ask18_2":   "If No, would you like assistance to develop such a plan?",
			"ask19":         "19) Are you familiar with Progressive Control Pathway for FMD control (PCP-FMD)?",
			
		"cat9": "SOCIO-ECONOMIC IMPACT",

			"ask20":        "20) Has the socio-economic impact of FMD been studied in your country? (exclusive)",
				"ask20_1":  "If yes, In which year was the study conducted?",
				"ask20_2":  "Which of the following sectors were included? (Multiple choices)",
				"ask20_3":  "Is the report available for our review?",
				"ask20_4":  "If possible, point of contact name and email:",
			
		"cat10": "SEROSURVEILLANCE",

			"ask21":        "21) Has your country conducted NSP serological surveillance with the purpose of estimating the prevalence of FMD viral circulation? (exclusive)",
				"aks21_1":  "If yes, which year(s)?",
				"aks21_2":  "Which attributes were included for the most recent survey? (check appropriate boxes)",
				"ask21_3":  "Is there a report available for our review? (exclusive)",
				"ask21_4":  "If possible, point of contact name and email:",
			"aks22":        "22) Which proportion of animals tested NSP-Antibodies positive (overall results) (exclusive):",
			"ask23":        "23) Which proportion of epidemiological units (farms, herds, villages, kraals)  had  1 or more NSP-Ab positive animals (exclusive):",
			
		"cat11": "VACCINATION",

			"ask24":                   "24) Is there a FMD national vaccination strategy endorsed by your government? (exclusive)",
			"ask25":                   "25) If yes, Please provide the information for the following species (check appropriate boxes)",
			
			
					"ask25_1_":       "Type of animal:",
					"ask25_2":       "Most recent implemented Year:",
					"ask25_3":       "Type of vaccination:",
					"ask25_4":       "Choose only one:",
					
					"ask25_4_1": "If the vaccine protocol is non-uniform, please choose all that apply below:",
		
					"ask25_4_1_1":       "Other:",
			
			
			
			"ask26":       "26) Indicate the Vaccine Name, Supplier, Species targeted and Serotypes (if unknown, please indicate with ‘?’):",
			"ask27":       "27) Number of doses applied in 2013 and 2014 (fill in the table below)",
			"ask28":       "28) Percentage of susceptible animals vaccinated by species in 2013 and 2014  (please, complete the table below)",
			"ask29":       "29) Does the owner contribute to cover the costs of vaccination? (exclusive)",
				"ask29_1": "If certain sectors, please explain:",
				"ask29_2": "If yes, % of cost covered by the owner  (exclusive)",

			"ask30":                     "30) Was vaccine quality assessed in 2013 and /or 2014? (exclusive)",
				"ask30_1":               "If yes:",
					"ask30_1_1":         "Who assessed the Vaccine Quality (exclusive):",
						"ask30_1_1_1":   "Other:",
					"ask30_1_2":         "Which of the following quality indicators were assessed? (check the year where they were assessed, more than one is possible)",
					"ask30_1_2_1":       "Vaccine matching: vaccine virus tested against with field strains at least once (Multiple choice)",
						"ask30_1_2_1_1": "Which Laboratory did the test?",
					"ask30_1_2_2":       "Vaccine potency: was the PD50 determined? (if yes, check  the year when it was assessed) (multiple answer)",
					"ask30_1_2_3":       "Immune response after vaccination (SP-Antibody response 30 days (or more) after vaccination) (multiple answer)",
					"ask30_1_2_4":       "Vaccine effectiveness studies: field study comparing occurrence of clinical FMD in vaccinated animals compared with non-vaccinated animals_ (multiple answer)",
					"ask30_1_2_5":       "Is the Vaccine Cold Chain monitored and assessed?",
				"ask30_2":               "How was it monitored and assessed?",
			
			
		"cat12": "EPIDEMIOLOGY AND LABORATORY NETWORKS",

			"ask31":       "31) Does your country belong to any Epidemiology Network which deals with FMD control? (exclusive)",
				"ask31_1": "If yes, please provide the name of the network:",
			"ask32":       "32) Does your country belong to any Laboratory Network which deals with FMD control? (exclusive)",
				"ask32_1": "If yes, please provide the name of the network:",
			
		"cat13": "ACTIVITIES TO COMBINE FMD AND OTHER DISEASES CONTROL",

			"ask33":       "33) Does your country perform any activity which combines FMD surveillance and/or control with activities related to other diseases? (i_e, use of serum samples to test for more than one disease including FMD, awareness campaign targeting multiple diseases, combination of vaccination strategies__) (exclusive):",
				"ask33_1": "If yes, please indicate each activity and diseases addressed in each one:",
			
		"cat14": "CHALLENGES",

			"ask34":       "34) Please indicate  the major challenges/difficulties your country is facing in controlling/eliminating FMD?  (Please,  Rank the  5 most significant challenges)",
			"ask35":       "35) Please indicate which of the following areas your country desires technical assistance and capacity building to improve your FMD control? (Please,  Rank the 5 top priorities from the list below)",
				"ask35_1": "Others:",
			
		"cat15": "GLOBAL FMD PORTFOLIO",

			"ask36":               "36) Has your country participated in any specific activities, programs or projects that involve FMD surveillance and/or control in the last 3 years? (please list as appropriate)",
				"ask36_1":         "If yes:",
				"ask36_1_1":       "What is the Geographic area of implementation? (exclusive)",
				"ask36_1_2":       "Project status (exclusive):",
				"ask36_1_3":       "Budget:",
					"ask36_1_3_1": "a_ Amount (USD)",
				"ask36_1_3_2":     "b_ Source of funds (multiple)",
				"ask36_1_3_3":     "Donors:",
				
			"ask36_2":       "Title of the  project:",
			"ask36_3":       "Objectives: (exclusive)",
				"ask36_3_1": "If Development project (medium to long term)",
			"ask36_4":       "Activities (multiple):",
				"ask36_4_1": "Others:",
			"ask36_5":       "Tools used: (multiple)",
				"ask36_5_1": "Others:"
	}
});
